SciNeuro Pharmaceuticals
Latest round
- Series B
Last raised
- Dec 2025
Total raised
- $153M
Investors
- 7
About SciNeuro Pharmaceuticals
, trading as SciNeuro Pharmaceuticals, is a biopharmaceutical company focusing on the research and development of central nervous system drugs. The company is committed to internal innovation and global collaboration by building its CNS product portfolio. The company mainly develops central nervous system drugs to treat neurodegenerative diseases such as Parkinson's disease (PD) and Alzheimer's disease (AD). Its R&D pipeline includes AD/Lp-PLA2, PD/alpha-synuclein, etc. The company generates revenue through research and development, production, and sales of new drugs for the central nervous system and other related products.
Who invested in SciNeuro Pharmaceuticals
7 investors across 2 rounds
See all investors in SciNeuro Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SciNeuro Pharmaceuticals
Who invested in SciNeuro Pharmaceuticals?
SciNeuro Pharmaceuticals has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SciNeuro Pharmaceuticals raised?
SciNeuro Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did SciNeuro Pharmaceuticals last raise money?
SciNeuro Pharmaceuticals's most recent round on record is a Series B, in Dec 2025.
What does SciNeuro Pharmaceuticals do?
, trading as SciNeuro Pharmaceuticals, is a biopharmaceutical company focusing on the research and development of central nervous system drugs.
Where is SciNeuro Pharmaceuticals headquartered?
SciNeuro Pharmaceuticals is headquartered in Rockville, US.
Which VCs invest in companies like SciNeuro Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at SciNeuro Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like SciNeuro Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.